Article

Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative…

Disease Markers · 2022 · Chia-Hung Hsu, author Hon-Ping Ma, author Jiann Ruey Ong, author Ming-Shou Hsieh, author Vijesh Kumar Yadav, author Chi-Tai Yeh, author Tsu-Yi Chao, author Wei-Hwa Lee, author Wen-Chien Huang, author Kuang-Tai Kuo, author Iat-Hang Fong, author Chih-Cheng Lin, author Chih-Ming Su, author Ihtisham Bukhari, Academic Editor

Key facts

Title Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression
First author Chia-Hung Hsu, author Hon-Ping Ma, author Jiann Ruey Ong, author Ming-Shou Hsieh, author Vijesh Kumar Yadav, author Chi-Tai Yeh, author Tsu-Yi Chao, author Wei-Hwa Lee, author Wen-Chien Huang, author Kuang-Tai Kuo, author Iat-Hang Fong, author Chih-Cheng Lin, author Chih-Ming Su, author Ihtisham Bukhari, Academic Editor
Journal Disease Markers
Published Jan 16, 2022
DOI 10.1155/2022/8446629
Devices mentioned K041074, K802418, K822496
Product codes mentioned GKZ, JIT, KIS, JJH

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature